[
    [
        {
            "time": "",
            "orginal_text": "华熙生物向中国少年儿童文化艺术基金会爱童工程捐赠物资",
            "features": {
                "keywords": [
                    "华熙生物",
                    "捐赠",
                    "物资"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "社会责任"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "华熙生物向中国少年儿童文化艺术基金会爱童工程捐赠物资",
            "scores": {
                "News_content": "华熙生物向中国少年儿童文化艺术基金会爱童工程捐赠物资",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 8,
                "Market_Scope": 2,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "华熙生物（688363）：科技力持续夯实 “四轮驱动”推动业绩快速增长",
            "features": {
                "keywords": [
                    "华熙生物",
                    "科技力",
                    "四轮驱动",
                    "业绩增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "华熙生物（688363）：科技力持续夯实 “四轮驱动”推动业绩快速增长",
            "scores": {
                "News_content": "华熙生物（688363）：科技力持续夯实 “四轮驱动”推动业绩快速增长",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "财信证券维持华熙生物推荐评级：功能性护肤品高增，生物活性物平台型企业初步成型",
            "features": {
                "keywords": [
                    "财信证券",
                    "华熙生物",
                    "推荐评级",
                    "功能性护肤品",
                    "生物活性物"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化妆品",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "财信证券维持华熙生物推荐评级：功能性护肤品高增，生物活性物平台型企业初步成型",
            "scores": {
                "News_content": "财信证券维持华熙生物推荐评级：功能性护肤品高增，生物活性物平台型企业初步成型",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "国信证券：维持华熙生物（688363.SH）“增持”评级 功能性护肤品业务表现亮眼",
            "features": {
                "keywords": [
                    "国信证券",
                    "华熙生物",
                    "增持评级",
                    "功能性护肤品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "化妆品"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "国信证券：维持华熙生物（688363.SH）“增持”评级 功能性护肤品业务表现亮眼",
            "scores": {
                "News_content": "国信证券：维持华熙生物（688363.SH）“增持”评级 功能性护肤品业务表现亮眼",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "华熙生物、昊海生科、爱美客医美“三剑客”业绩大增！行业监管趋严下有哪些新增长引擎？",
            "features": {
                "keywords": [
                    "华熙生物",
                    "昊海生科",
                    "爱美客",
                    "医美",
                    "业绩大增",
                    "行业监管",
                    "新增长引擎"
                ],
                "sentiment_score": 0.65,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医美",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "华熙生物、昊海生科、爱美客医美“三剑客”业绩大增！行业监管趋严下有哪些新增长引擎？",
            "scores": {
                "News_content": "华熙生物、昊海生科、爱美客医美“三剑客”业绩大增！行业监管趋严下有哪些新增长引擎？",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]